Genentech pays $200M for Vaccibody’s phase 1 cancer vaccine

Genentech pays $200M for Vaccibody’s phase 1 cancer vaccine
ntaylor
Thu, 10/01/2020 – 08:00

Published on Thu, 01 Oct 2020 12:00:26 +0000 and brought to you by Apptigent PowerTools